TMOQT67Thermo Fisher Scientific Inc.·NYSE
673.82-0.40%
TA
Loading chart...
Screen all →
Snapshot
IndexS&P 500P/E35.54EPS (ttm)18.96Insider Own0.15%Shs Outstand369.75MPerf Week-2.34%
Market Cap249.14BForward P/E24.38EPS next Y27.64Insider Trans-18.26%Shs Float368.79MPerf Month-0.67%
Enterprise Value284.45BPEG3.60EPS next Q-Inst Own87.56%Short Float1.47%Perf Quarter20.43%
Income7.08BP/S5.26EPS this Y10.92%Inst Trans0.00%Short Ratio2.64Perf Half Y43.45%
Sales47.35BP/B4.54EPS next Y9.55%ROA6.20%Short Interest5.41MPerf YTD16.29%
Book/sh148.47P/C41.11EPS next 5Y10.06%ROE13.31%52W High705.79 -4.53%Perf Year18.80%
Cash/sh16.39P/FCF32.80EPS past 3/5Y0.19% 2.11%ROIC7.54%52W Low435.26 54.81%Perf 3Y44.21%
Dividend Est.1.88 (0.28%)EV/EBITDA25.30Sales past 3/5Y-0.27% 6.70%Gross Margin41.44%Volatility3.55% 3.04%Perf 5Y15.70%
Dividend TTM1.84 (0.27%)EV/Sales6.01EPS Y/Y TTM14.70%Oper. Margin17.98%ATR (14)20.55Perf 10Y343.22%
Dividend Ex-DateSep 15, 2026Quick Ratio1.41Sales Y/Y TTM10.43%Profit Margin14.96%RSI (14)53.81Recom2.16
Dividend Gr. 3/5Y12.75% 14.34%Current Ratio1.81EPS Q/Q15.37%SMA200.26%Beta0.84Target Price688.14
Payout9.50%Debt/Eq0.74Sales Q/Q9.13%SMA504.47%Rel Volume0.95Prev Close676.54
Employees125,000LT Debt/Eq0.67EarningsFeb 04SMA20022.67%Avg Volume2.14MPrice673.82
IPO DateMar 17, 1980Option/ShortYes / YesEPS/Sales Surpr.4.32% 1.54%Net Debt/EBITDA3.19Volume2,032,377Change-0.40%
Analyst Ratings
DateActionAnalystRatingTarget
Oct-22-26ReiteratedUBSNeutral$730 → $800
Oct-22-26ReiteratedStifel NicolausBuy$650 → $775
Oct-22-26ReiteratedRobert W. Baird$723 → $756
Oct-22-26ReiteratedRBC CapitalSector Perform$740 → $730
Oct-22-26ReiteratedBarclaysOverweight$750 → $775
Oct-15-26ReiteratedRBC CapitalSector Perform$580 → $740
Oct-15-26InitiatedGuggenheimBuy$740
Oct-07-26ReiteratedBarclaysOverweight$650 → $750
Sep-25-26ReiteratedDeutsche BankBuy$635 → $720
Sep-08-26ReiteratedUBSNeutral$615 → $730
Latest News· Times ET
Oct-23-26
Oct-21-26
Oct-20-26
Company

Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.

Ownership
Total institutional ownership87.56%

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue47,35144,55742,879——————
Cost of Goods Sold Incl. D&A27,72926,31825,151——————
Gross Profit19,62218,23917,728——————
Selling, General and Administrative Excl. Other7,9228,7328,676——————
Research and Development1,4051,3971,390——————
Other Operating Expense
1,77900——————
Operating Income8,5158,1097,662——————
Interest Expense1,5371,4191,654——————
Unusual Expense
—————————
Non-Operating Income (Expense)891577987——————
Net Income Before Taxes7,8697,2676,995——————
Income Taxes742547657——————
Consolidated Net Income7,0836,7376,335——————
Net Income From Continuing Operations7,1276,7206,338——————
Net Income7,0836,7376,335——————
EPS (Recurring)18.9917.7716.58——————
EPS (Basic, Before Extraordinaries)18.9917.7716.58——————
EPS (Diluted)18.9617.7416.53——————
EBITDA11,24111,46611,800——————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio35.5432.6631.47——————
Price To Sales Ratio5.274.894.63——————
Gross Margin41.4440.9341.34——————
Operating Margin17.9818.2017.87——————
Net Margin14.9615.1214.77——————
Shares Outstanding370376382——————
Market Capitalization249,313217,873198,728——————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$735.21$651.31$567.41$483.52$399.62● Close Price0.00M15.33M30.67M46.00M61.33MUSD Trades VolumeOctNovDec2026FebMarAprMayJunJulAugSepOct
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Pettiti GianlucaPresident & COOAug 31 '26Sale614.384,1332,539,23323,216Sep 01
Pettiti GianlucaPresident & COOAug 31 '26Option Exercise309.633,7331,155,84926,949Sep 01
CASPER MARC NChairman & CEOAug 24 '26Option Exercise309.6327585,148124,200Aug 26
CASPER MARC NChairman & CEOAug 24 '26Sale627.05275172,438123,925Aug 26
CASPER MARC NChairman & CEOAug 21 '26Sale626.9210,0006,269,152123,925Aug 24
CASPER MARC NChairman & CEOAug 21 '26Option Exercise309.6310,0003,096,300133,925Aug 24
CASPER MARC NChairman & CEOAug 20 '26Sale629.2710,0006,292,669123,925Aug 24
CASPER MARC NChairman & CEOAug 20 '26Option Exercise309.6310,0003,096,300133,925Aug 24
Britt Lisa P.Sr. VP and Chief HR OfficerAug 19 '26Option Exercise418.3211,4404,785,58126,224Aug 20
Britt Lisa P.Sr. VP and Chief HR OfficerAug 19 '26Sale613.1211,4407,014,09314,784Aug 20
Shafer Michael DExecutive Vice PresidentAug 11 '26Option Exercise370.5825,5009,449,83235,294Aug 13
Shafer Michael DExecutive Vice PresidentAug 11 '26Sale600.0025,50015,300,00020,994Aug 13
CASPER MARC NChairman & CEOAug 07 '26Sale586.124,8832,862,0010Aug 10
Holmes Joseph R.VP & Chief Accounting OfficerAug 07 '26Option Exercise309.63420130,0453,386Aug 10
Holmes Joseph R.VP & Chief Accounting OfficerAug 07 '26Sale584.81420245,6202,966Aug 10
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.